NeuBase Therapeutics, Inc. Annual Interest Expense in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2022.
  • NeuBase Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2023 was $122.000, a 95.5% decline year-over-year.
  • NeuBase Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2023 was $5.07K, a 78.9% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2022 was $24K, a 25.6% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2021 was $32.3K, a 321% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Interest Expense for 2020 was $7.69K, a 94% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $24K -$8.28K -25.6% Oct 1, 2021 Sep 30, 2022 10-K 2022-12-21
2021 $32.3K +$24.6K +321% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-21
2020 $7.69K -$121K -94% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 $129K Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2015 $5.98K +$401 +7.19% Oct 1, 2014 Sep 30, 2015 10-K 2015-12-14
2014 $5.58K +$887 +18.9% Oct 1, 2013 Sep 30, 2014 10-K 2015-12-14
2013 $4.69K +$2.87K +158% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-14
2012 $1.82K -$616 -25.3% Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
2011 $2.43K -$19.1K -88.7% Oct 1, 2010 Sep 30, 2011 10-K 2013-01-09
2010 $21.5K Oct 1, 2009 Sep 30, 2010 10-K/A 2012-01-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.